Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01687114 · ClinicalTrials.gov registry record · NA
Urinary Proanthocyanidin-A2 as a Biomarker of Compliance to Intake of Cranberry Products
A NA study, sponsored by Tufts University.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT01687114 is a NA study that has completed, run by Tufts University. The registered enrollment target is 5 participants.
The verdict
NCT01687114, a NA study, has completed, sponsored by Tufts University.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This protocol is a clinical trial to validate proanthocyanidin A2 (PAC-A2) as a useful marker of cranberry intake. We hypothesize the consumption of this cranberry beverage in a progressive dosing schedule will increase PAC-A2 excretion in urine. Five generally healthy, nonsmoking, pre-menopausal women (absent major chronic diseases including cardiovascular, endocrine, gastrointestinal, and renal conditions), age 20-40 years, with a body mass index (BMI) of 18.5-25 kg/m2 will be recruited from the Boston area because sexually active women in this age range are particularly vulnerable to urinary tract infection. Volunteers will be asked to consume their assigned cranberry beverage at a dose of 8 oz/day according to a weekly dosing schedule. Relevant clinical information and eleven 24-hour and morning spot urine samples each will be collected from subjects during the study. Urinary PAC-A2 concentration will then be determined to validate if it can serve as a marker of compliance of cranberry juice consumption.
Interventions
- OTHER cranberry juice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2012-09 |
| Est. Completion | 2014-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01687114
The ClinicalTrials.gov registry entry for NCT01687114 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which cranberry juice is the first listed.
NCT01687114 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01687114 about?
NCT01687114 is a clinical study titled "Urinary Proanthocyanidin-A2 as a Biomarker of Compliance to Intake of Cranberry Products". This protocol is a clinical trial to validate proanthocyanidin A2 (PAC-A2) as a useful marker of cranberry intake. We hypothesize the consumption of this cranberry beverage in a progressive dosing schedule will increase PAC-A2 excretion in urine. Five generally healthy, nonsmoking, pre-menopausal wo...
What is the current status of trial NCT01687114?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2012-09. Estimated completion is 2014-04.
What interventions are being tested in trial NCT01687114?
The interventions under investigation include: cranberry juice (OTHER).
Who is sponsoring clinical trial NCT01687114?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.